Anbio Biotechnology Class A Ordinary Shares (NASDAQ:NNNN) — Market Cap & Net Worth
Market Cap & Net Worth: Anbio Biotechnology Class A Ordinary Shares (NNNN)
Anbio Biotechnology Class A Ordinary Shares (NASDAQ:NNNN) has a market capitalization of $696.11 Million ($696.11 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #10776 globally and #2763 in its home market, demonstrating a -1.86% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anbio Biotechnology Class A Ordinary Shares's stock price $15.86 by its total outstanding shares 43891200 (43.89 Million). Review total liabilities of Anbio Biotechnology Class A Ordinary Sha to assess the company's total debt and financial obligations.
Anbio Biotechnology Class A Ordinary Shares Market Cap History: 2025 to 2026
Anbio Biotechnology Class A Ordinary Shares's market capitalization history from 2025 to 2026. Data shows growth from $1.32 Billion to $696.11 Million (0.00% CAGR).
Index Memberships
Anbio Biotechnology Class A Ordinary Shares is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.03% | #290 of 976 |
Weight: Anbio Biotechnology Class A Ordinary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Anbio Biotechnology Class A Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Anbio Biotechnology Class A Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
135.25x
Anbio Biotechnology Class A Ordinary Shares's market cap is 135.25 times its annual revenue
Latest Price to Earnings (P/E) Ratio
182.63x
Anbio Biotechnology Class A Ordinary Shares's market cap is 182.63 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $1.32 Billion | $9.76 Million | $7.23 Million | 135.25x | 182.63x |
Competitor Companies of NNNN by Market Capitalization
Companies near Anbio Biotechnology Class A Ordinary Shares in the global market cap rankings as of June 18, 2026.
Key companies related to Anbio Biotechnology Class A Ordinary Shares by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #164 globally with a market cap of $142.44 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #267 globally with a market cap of $94.60 Billion USD ( €80.92 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #340 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #542 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #164 | Intuitive Surgical Inc | NASDAQ:ISRG | $142.44 Billion | $402.18 |
| #267 | EssilorLuxottica S. A. | PA:EL | $94.60 Billion | €174.75 |
| #340 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €91.50 |
| #542 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Anbio Biotechnology Class A Ordinary Shares Historical Marketcap From 2025 to 2026
Between 2025 and today, Anbio Biotechnology Class A Ordinary Shares's market cap moved from $1.32 Billion to $ 696.11 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $696.11 Million | -47.26% |
| 2025 | $1.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Anbio Biotechnology Class A Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $696.11 Million USD |
| MoneyControl | $696.11 Million USD |
| MarketWatch | $696.11 Million USD |
| marketcap.company | $696.11 Million USD |
| Reuters | $696.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/… Read more